IceCure Medical Ltd
$1.36
-0.01 (-0.73%)
ICCM Price Chart
| Basic | |
|---|---|
| Market Cap | $73.95M |
| Price | $1.36 |
| 52 Week Range | 0.48-1.45 |
| Beta | 2.63 |
| Margins | |
| Gross Profit Margin | 44.11% |
| Operating Profit Margin | -476.91% |
| Net Profit Margin | -465.41% |
| Valuation (TTM) | |
| P/E Ratio | -3.67 |
| Price to Sales Ratio | 19.64 |
| Price to Book Ratio | 8.13 |
| PEG Ratio | 0.39 |
Industry
Medical - Devices
Sector
Healthcare
Full-Time Employees
71
IPO Date
2021-08-26T00:00:00.000Z
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Phone
972 4 623 0333
Address
7 Ha’Eshel Street, Caesarea, 3079504, IL
CIK
0001584371